Evidence map›Paper›PMID 38943321›Full record

ArticleNucleic acids research2024

PRPF40A induces inclusion of exons in GC-rich regions important for human myeloid cell differentiation.

Cheryl Weiqi Tan, Donald Yuhui Sim, Yashu Zhen, Haobo Tian, Jace Koh, Xavier Roca

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cheryl Weiqi TanSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.
Donald Yuhui SimSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.
Yashu ZhenSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.
Haobo TianSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.
Jace KohSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.
Xavier RocaSchool of Biological Sciences, Nanyang Technological University, 637551 Singapore.ORCID 0000-0003-3853-5273

Funding

Singapore National Research Foundation NRF2019-NRF-ISF003-3104Singapore's Ministry of Education
6 · The paper itself

Abstract

We characterized the regulatory mechanisms and role in human myeloid cell survival and differentiation of PRPF40A, a splicing factor lacking a canonical RNA Binding Domain. Upon PRPF40A knockdown, HL-60 cells displayed increased cell death, decreased proliferation and slight differentiation phenotype with upregulation of immune activation genes. Suggestive of both redundant and specific functions, cell death but not proliferation was rescued by overexpression of its paralog PRPF40B. Transcriptomic analysis revealed the predominant role of PRPF40A as an activator of cassette exon inclusion of functionally relevant splicing events. Mechanistically, the exons exclusively upregulated by PRPF40A are flanked by short and GC-rich introns which tend to localize to nuclear speckles in the nucleus center. These PRPF40A regulatory features are shared with other splicing regulators such as SRRM2, SON, PCBP1/2, and to a lesser extent TRA2B and SRSF2, as a part of a functional network that regulates splicing partly via co-localization in the nucleus.

Indexed as

Cell DifferentiationExonsMyeloid CellsAlternative SplicingCell NucleusCell ProliferationHL-60 CellsHumansIntronsRNA-Binding ProteinsRNA SplicingRNA Splicing FactorsSerine-Arginine Splicing FactorsRNA-Binding ProteinsRNA Splicing FactorsSerine-Arginine Splicing Factors

Identifiers

PMID38943321
PMCPMC11347146

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.